Company Data

Intellia Therapeutics Inc.

Ticker
NTLA
Current Price
$12.28 6.5%
Market Cap
$1.3B
Price Target
Refer to Report
Volume
5.9M
52wk Range
$8.96 - $34.87
Advanced Market Data

Overview

Intellia Therapeutics Inc is a genome editing company. It is engaged in developing curative therapeutics utilizing a biological tool known as CRISPR/Cas9.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy